2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | - | 17.976 | 17.997 | - | - | - | 17.986 | 17.896 | 17.983 | 17.994 |
Total Income - EUR | - | 18.047 | 18.461 | - | - | - | 17.986 | 17.896 | 17.983 | 17.994 |
Total Expenses - EUR | - | 61.891 | 30.405 | - | - | - | 24.879 | 24.670 | 22.200 | 18.502 |
Gross Profit/Loss - EUR | - | -43.843 | -11.944 | - | - | - | -6.893 | -6.774 | -4.217 | -508 |
Net Profit/Loss - EUR | - | -43.960 | -12.313 | - | - | - | -7.433 | -7.311 | -4.756 | -1.748 |
Employees | - | 1 | 1 | - | - | - | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Imunofarm Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | - | 49.146 | 48.028 | - | - | - | 55.300 | 51.048 | 49.311 | 50.539 |
Current Assets | - | 17.453 | 10.596 | - | - | - | 3.353 | 3.255 | 4.450 | 1.130 |
Inventories | - | 1.348 | 1.365 | - | - | - | 302 | 21 | 21 | 0 |
Receivables | - | 7.480 | 6.819 | - | - | - | 1.009 | 1.182 | 2.387 | 349 |
Cash | - | 8.625 | 2.412 | - | - | - | 2.042 | 2.052 | 2.042 | 780 |
Shareholders Funds | - | 26.315 | 13.734 | - | - | - | -4.478 | -11.690 | -19.851 | -21.538 |
Social Capital | - | 225 | 223 | - | - | - | 207 | 202 | 203 | 202 |
Debts | - | 41.536 | 46.999 | - | - | - | 63.132 | 65.993 | 73.611 | 73.208 |
Income in Advance | - | 0 | 0 | - | - | - | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "4773 - 4773" | |||||||||
CAEN Financial Year |
4773
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Imunofarm Srl